Stealth's lead drug flunks again, this time in an eye disease, but biotech will attempt to push forward
May 2, 2022, 5:13 pm
The Santa Monica, CA-based biotech’s stock shot up early Friday on reports that it had agreed to a licensing deal with Hikma Pharmaceuticals on an experimental nasal spray to treat opioid overdoses.
